Hottod your research is always exceptional!
1. I had a look into what their result for 22/23 and it seems to be about 187m - so 60% growth that year. Followed by 35% growth for 23/24. And further slowed to 30% the next year as they guided. They estimate the market at 3.75-4.2 billion so I would say plenty of room for both companies.
2. With regards to adjusting for the index - maybe not a good comparison as the index is weighted so heavily made up of much more developed companies that would be paying dividends and not growing much beyond inflation.
3. Yes Kerecis has much higher revenue. Though at the time of acquisition I remember looking into it and it was much higher priced so in terms of product used it was quite similar. Do you have any info on what they are charging?
4. Would also be interesting to know what their cost base is?
5. Do you know why BTM was denied LCD? Seems strange given the attractive cost.
6. Are you aware Kerecis pays physicians far more than PNV do - seems they have been a lot more aggressive in this area. These payments are for speaking and education engagements. The bulk of the below payment from Kerecis was in 2023 ($4,220,387.75)
(20min delay)